The Department of Health has today awarded Birmingham £12m to help advance research into inflammatory diseases.


The funding from the National Institute of Health Research  (NIHR) for the Birmingham Biomedical Research Centre (BRC) in Inflammation combines our world-class strengths in immunology and inflammation research and extensive experimental medicine infrastructure. This will support a five-year programme between the NHS and University as core partners of Birmingham Health Partners (BHP) to better understand and treat a range of debilitating diseases for patients in Birmingham and beyond.

Professor David Adams, Head of the College of Medical and Dental Sciences, Director of Birmingham Health Partners and the new Birmingham NIHR BRC comments; “We are delighted that the NIHR have funded a Biomedical Research Centre in inflammatory disease in Birmingham.  We will build a centre of excellence that will allow us to take scientific discoveries through into new treatments for patients with inflammatory and autoimmune joint, muscle, bowel and liver diseases.

“Chronic inflammatory diseases such as arthritis, colitis and liver diseases are increasingly common and a major cause of suffering and early death.  In Birmingham, we have been researching the underlying processes behind these diseases for many years.  This award will enable the University and University Hospitals Birmingham to continue to develop the facilities and teams to help better understand and treat these disabling diseases.”

Through this funding, leading NHS clinicians and top universities throughout the UK will benefit from new world class facilities and support services built by the five-year funding package – the largest ever investment into health research.

University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham are one of 20 NHS and University partnerships across England, who have each been awarded funding through the National Institute for Health Research, boosting growth in cities across the country.

Each of the new Biomedical Research Centres will host the development of new, ground-breaking treatments, diagnostics, prevention and care for patients in a wide range of diseases like cancer and dementia.